Breaking News - The Fly

Open Search

MRTX

Mirati Therapeutics

$

()

Rocket Pharmaceuticals names Aaron Ondrey as new CFO

RCKT , MRTX

3/26/2024 - 16:03pm

Two new option listings and option delistings on February 26th

AHR , ASTH , OTRK

…

2/26/2024 - 08:30am

Corcept Therapeutics appoints Roberto Vieria as president, oncology

CORT , MRTX

1/29/2024 - 08:14am

Bristol Myers completes acquisition of Mirati Therapeutics

BMY , MRTX

1/23/2024 - 09:20am

Mirati Therapeutics receives conditional authorization for KRAZATI from EC

MRTX

1/10/2024 - 08:02am

The biopharmaceuticals stocks to own in 2024, according to BofA

LLY , MRK , GILD

…

1/3/2024 - 10:47am

Bristol Myers downgraded to Neutral at BofA as more clarity on execution awaited

BMY , MRTX , KRTX

…

1/3/2024 - 06:12am

Mirati Therapeutics downgraded to Neutral from Buy at Citi

MRTX , BMY

12/20/2023 - 05:10am

Mirati Therapeutics' Krazati receives positive opinion in NSLC from CHMP

MRTX

11/10/2023 - 07:34am

Leerink downgrades Mirati to Market Perform as focus remains on acquisition

MRTX , BMY

11/7/2023 - 06:22am

Mirati Therapeutics downgraded to Market Perform from Outperform at Leerink

MRTX

11/7/2023 - 06:17am

Mirati Therapeutics downgraded to Hold on pending buyout at Stifel

MRTX , BMY

11/7/2023 - 05:09am

Mirati Therapeutics downgraded to Hold from Buy at Stifel

MRTX

11/6/2023 - 16:58pm

Mirati Therapeutics reports Q3 EPS ($2.49), consensus ($2.83)

MRTX

11/6/2023 - 08:05am

Mirati Therapeutics receives MHRA approval for KRAZATI

MRTX

11/3/2023 - 17:59pm